Live Breaking News & Updates on அடுத்தது ஜெநரேஶந் ப்ரோபிஒடிக்ஸ்
Stay updated with breaking news from அடுத்தது ஜெநரேஶந் ப்ரோபிஒடிக்ஸ். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Global Nutrigenomics Market to 2031 - Increasing Demand for Preventive Medication Through Personalized Nutrition prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global Nutrigenomics Market to 2031 - Increasing Demand for Preventive Medication Through Personalized Nutrition prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
A robust research and innovation ecosystem makes Italy an attractive life sciences hotspot, according to a post from an Italian trade delegation at Bio Digital 2021. ....
On April 12, 2021, Sequentia Biotech, a Spanish omics company, and NextBiomics, a biotech company involved in the research and development of Next Generation Probiotics and a spin-off of the Federico II University of Naples, announced the filing of a patent application for a bacterial vaccine against the COVID-19 syndrome. By engineering the probiotic Escherichia Coli Nissle 1917 expressing the SARS-CoV-2 Spike protein, it was possible to obtain an innovative model of immunization against COVID-19 by stimulating the intestinal immune system”, Giovanni Sarnelli “The NEXBIOMICS vaccine is similar to others that have been already authorized (Pfizer, Moderna, AstraZeneca, Reithera, Johnson & Johnson) in that it stimulates the immune response against the Spike protein that the Coronavirus uses to infect cells, but it differs from them because it uses a probiotic bacterium as a vector, which is already on the market and being widely used for other purposes. ....